| Ashmont Counseling Associates Llc | |
|
172 Ashmont St Dorchester Center MA 02124-3745 | |
| (617) 224-7289 | |
| (617) 288-2992 |
| Full Name | Ashmont Counseling Associates Llc |
|---|---|
| Speciality | Psychologist |
| Location | 172 Ashmont St, Dorchester Center, Massachusetts |
| Authorized Official Name and Position | Martin Randy Pierre (LICENSED PSYCHOLOGIST) |
| Authorized Official Contact | 6172247289 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ashmont Counseling Associates Llc 172 Ashmont St Dorchester Center MA 02124-3745 Ph: (617) 224-7289 | Ashmont Counseling Associates Llc 172 Ashmont St Dorchester Center MA 02124-3745 Ph: (617) 224-7289 |
| NPI Number | 1003099417 |
|---|---|
| Provider Enumeration Date | 12/07/2007 |
| Last Update Date | 12/20/2007 |
| Medicare PECOS PAC ID | 5991886731 |
|---|---|
| Medicare Enrollment ID | O20080117000377 |
News Archive
Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children. Infertility caused by chemotherapy and radiation affects a sizable population: Of the 1.5 million people diagnosed with cancer in 2009, nearly 10 percent were still in their reproductive years.
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
Microcapsules with a broad spectrum of applications in biomedicine, catalysis, and technology can be produced by using plant-derived, phenolic tannic acid and a variety of metals. The capsules are formed by a simple self-assembly process, and their properties can be controlled through the choice of metal, as demonstrated by a team of Australian and German researchers in the journal Angewandte Chemie.
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher.
The TF3 consortium has been chosen to provide a Remote Telemonitoring Service to Northern Ireland which will support over 8,000 patients during the course of the contract.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003099417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | 8761 (Massachusetts) | Primary |
| Provider Name | Dennis E Tyrell |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1801809181 PECOS PAC ID: 5193728533 Enrollment ID: I20060919000025 |
News Archive
Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children. Infertility caused by chemotherapy and radiation affects a sizable population: Of the 1.5 million people diagnosed with cancer in 2009, nearly 10 percent were still in their reproductive years.
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
Microcapsules with a broad spectrum of applications in biomedicine, catalysis, and technology can be produced by using plant-derived, phenolic tannic acid and a variety of metals. The capsules are formed by a simple self-assembly process, and their properties can be controlled through the choice of metal, as demonstrated by a team of Australian and German researchers in the journal Angewandte Chemie.
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher.
The TF3 consortium has been chosen to provide a Remote Telemonitoring Service to Northern Ireland which will support over 8,000 patients during the course of the contract.
› Verified 7 days ago
| Provider Name | Martin R Pierre |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1962698407 PECOS PAC ID: 3870674617 Enrollment ID: I20080117000417 |
News Archive
Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children. Infertility caused by chemotherapy and radiation affects a sizable population: Of the 1.5 million people diagnosed with cancer in 2009, nearly 10 percent were still in their reproductive years.
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
Microcapsules with a broad spectrum of applications in biomedicine, catalysis, and technology can be produced by using plant-derived, phenolic tannic acid and a variety of metals. The capsules are formed by a simple self-assembly process, and their properties can be controlled through the choice of metal, as demonstrated by a team of Australian and German researchers in the journal Angewandte Chemie.
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher.
The TF3 consortium has been chosen to provide a Remote Telemonitoring Service to Northern Ireland which will support over 8,000 patients during the course of the contract.
› Verified 7 days ago
News Archive
Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children. Infertility caused by chemotherapy and radiation affects a sizable population: Of the 1.5 million people diagnosed with cancer in 2009, nearly 10 percent were still in their reproductive years.
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
Microcapsules with a broad spectrum of applications in biomedicine, catalysis, and technology can be produced by using plant-derived, phenolic tannic acid and a variety of metals. The capsules are formed by a simple self-assembly process, and their properties can be controlled through the choice of metal, as demonstrated by a team of Australian and German researchers in the journal Angewandte Chemie.
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher.
The TF3 consortium has been chosen to provide a Remote Telemonitoring Service to Northern Ireland which will support over 8,000 patients during the course of the contract.
› Verified 7 days ago
Academic & Behavioral Clinic Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 995 Blue Hill Ave, Dorchester Center, MA 02124 Phone: 617-822-0829 Fax: 617-825-7804 | |
Academic & Behavioral Assessment Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 895 Blue Hill Ave, Dorchester Center, MA 02124 Phone: 617-822-0829 Fax: 617-825-7804 | |
Carney Hospital Psychiatric Unit Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2100 Dorchester Ave, Dorchester Center, MA 02124 Phone: 617-296-4000 Fax: 617-562-7241 | |
Codman Square Health Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 637 Washington St, Dorchester Center, MA 02124 Phone: 617-825-9660 | |
Sport Development Services Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 19 Boyden St, Dorchester Center, MA 02124 Phone: 781-244-0894 | |
Boston Neurological Consultants Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2100 Dorchester Ave, Room 2208, Dorchester Center, MA 02124 Phone: 617-296-1925 |